Business
Health
A Rare Kidney Disease Approval Turns Travere Therapeutics Profitable While Hedge Funds Split on the Stock
By Raj Gupta
Travere Therapeutics shares closed at $57.36 on July 24, more than triple the $15.03 low…
Home
In Cary’s humid climate, mold isn’t just an occasional nuisance—it’s a persistent and potentially hazardous…
If you’ve ever tried relocating homes in Abu Dhabi, you know it’s more than just…
When planning a move, most people focus on packing, logistics, and hiring a moving company.…
Water damage is a serious issue that can disrupt homes and businesses alike. In Plainfield,…